Literature DB >> 8216202

Molecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering.

S J Perkins1, K F Smith, R B Sim.   

Abstract

Factor I is a typical multidomain protein of the complement system. It regulates complement activation by proteolytic degradation of C3b or C4b in the presence of factor H, complement receptor type 1, membrane cofactor protein or C4b-binding protein as cofactor. It is constructed from five presumed independently folded domains, namely a factor I module, a CD5-like domain, two low-density-lipoprotein receptor type A domains and a serine-proteinase domain. X-ray and neutron solution scattering was used to study the arrangement of these domains in factor I. Factor I was determined to be monomeric in solution, with an A280(1%,1cm) of 12.3-14.1. Its radius of gyration (RG) was 3.96 nm by X-rays in a high positive solute-solvent contrast, and 3.84 nm by neutrons at infinite solute-solvent contrast. The cross-sectional radius of gyration (RXS) was likewise found to be 1.64 nm by X-rays and 1.55 nm by neutrons. The RG data were not noticeably dependent on the solute-solvent contrast, whereas the RXS data showed a small dependence. The maximum dimension of factor I was determined to be 12.8 nm from the RG and RXS data, and 14-15 nm from the X-ray and neutron distance distribution functions. This length is too short to account for a linear arrangement of the domains in factor I. Small sphere models were developed for factor I in which the largest domain was modelled from the crystal structure for beta-trypsin. The attachment of either an elliptical cylinder or a two-armed V-shaped structure to this domain to represent the remaining four small domains gave good scattering curve-fits for factor I, and were compatible with experimental sedimentation coefficients. The non-extended domain models for factor I imply that the steric accessibility of each domain will be reduced, and this may be important for its functional activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216202      PMCID: PMC1134825          DOI: 10.1042/bj2950101

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  X-RAY SMALL ANGLE SCATTERING WITH SUBSTANCES OF BIOLOGICAL INTEREST IN DILUTED SOLUTIONS.

Authors:  O KRATKY
Journal:  Prog Biophys Mol Biol       Date:  1963       Impact factor: 3.667

2.  Structural invariants in protein folding.

Authors:  C Chothia
Journal:  Nature       Date:  1975-03-27       Impact factor: 49.962

3.  Purification of C3b inactivator and demonstration of its two polypeptide chain structure.

Authors:  D T Fearon
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

4.  Hydrodynamics of macromolecular complexes. III. Bacterial viruses.

Authors:  J G De La Torre; V A Bloomfield
Journal:  Biopolymers       Date:  1977-08       Impact factor: 2.505

5.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.

Authors:  I Gigli; T Fujita; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.

Authors:  S Nagasawa; C Ichihara; R M Stroud
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

8.  Purification of the human complement control protein C3b inactivator.

Authors:  L G Crossley; R R Porter
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

9.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.

Authors:  T Fujita; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  6 in total

1.  Analysis of binding sites on complement factor I using artificial N-linked glycosylation.

Authors:  Jose I Sanchez-Gallego; Tom W L Groeneveld; Stefanie Krentz; Sara C Nilsson; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

2.  Analysis of binding sites on complement factor I that are required for its activity.

Authors:  Sara C Nilsson; Izabela Nita; Lisa Månsson; Tom W L Groeneveld; Leendert A Trouw; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

3.  Construction of hydrodynamic bead models from high-resolution X-ray crystallographic or nuclear magnetic resonance data.

Authors:  O Byron
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

4.  Interactions between human complement components factor H, factor I and C3b.

Authors:  C J Soames; R B Sim
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures.

Authors:  S J Perkins; K F Smith
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  A Personal Tribute to Robert B. Sim with Reflections on Our Work Together on Factor H.

Authors:  Anthony J Day
Journal:  Viruses       Date:  2021-06-28       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.